VERU INC. Restricted Cash and Cash Equivalents
VERU INC. (VERU) had Restricted Cash and Cash Equivalents of $52.27 thousand as of 2013-06-30, per its 10-Q filed 2013-08-01.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2013-08-01
- 2013-06-30: Restricted Cash and Cash Equivalents $52.27K.
- 2013-03-31: Restricted Cash and Cash Equivalents $52.07K.
- 2012-12-31: Restricted Cash and Cash Equivalents $55.51K.
- 2012-09-30: Restricted Cash and Cash Equivalents $4.68K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2013-06-30 | $52.27K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $52.07K 10-Q · filed 2013-05-02 |
| 2012-12-31 | $55.51K 10-Q · filed 2013-01-30 |
| 2012-09-30 | $4.68K 10-Q · filed 2013-08-01 |
| 2012-06-30 | $4.52K 10-Q · filed 2012-07-31 |
| 2012-03-31 | $4.63K 10-Q · filed 2012-05-01 |
| 2011-12-31 | $4.48K 10-Q · filed 2012-01-31 |
| 2011-09-30 | $4.53K 10-K · filed 2012-12-04 |
| 2011-06-30 | $4.64K 10-Q · filed 2011-08-05 |
| 2010-09-30 | $4.58K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |